AI Article Synopsis
Article Abstract
Background: Ubinuclein-2 (UBN2) is a nuclear protein that interacts with many transcription factors. The molecular role and mechanism of UBN2 in the development and progression of cancers, including colorectal cancer (CRC), is not well understood. The current study explored the role of UBN2 in the development and progression CRC.
Methods: Oncomine network and The Cancer Genome Atlas (TCGA) database were downloaded and Gene Set Enrichment Analysis (GSEA) was performed to compare the UBN2's expression between normal and tumor tissues, as well as the potential correlation of UBN2 expression with signaling pathways. Immunohistochemistry (IHC), qRT-PCR and Western blotting were performed to determine the expression of UBN2 in CRC tissues or cell lines. In vitro proliferation and invasion assays, and orthotopic mouse metastatic model were used to analyze the effect of UBN2 on the development and progression of CRC.
Results: The analysis of UBN2 expression using Oncomine network showed that UBN2 was upregulated in CRC tissues compared to matched adjacent normal intestinal epithelial tissues. IHC, qRT-PCR and Western blotting confirmed that UBN2 expression is higher in CRC tissues compared with matched adjacent normal intestinal epithelial tissues. In addition, analyses of TCGA data revealed that high UBN2 expression was associated with advanced stages of lymph node metastasis, distant metastasis, and short survival time in CRC patients. IHC showed that high UBN2 expression is correlated with advanced stages of CRC. Moreover, UBN2 is highly expressed in the liver metastatic lesions. Furthermore, knockdown of UBN2 inhibited the growth, invasiveness and metastasis of CRC cells via regulation of the Ras/MAPK signaling pathway.
Conclusion: The current study demonstrates that UBN2 promotes tumor progression in CRC. UBN2 may be used as a promising biomarker for predicting the prognosis of CRC patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511126 | PMC |
| http://dx.doi.org/10.1186/s12935-019-0848-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
MiR-455-3p mediates PPARα through UBN2 to promote apoptosis and autophagy in acute myeloid leukemia cells.
Exp Hematol
December 2023
Department of Hematology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. Electronic address:
Acute myeloid leukemia (AML) is one of the deadliest hematologic malignancies, and its targeted therapy has developed slowly. The molecular mechanism of the pathophysiology of the disease remains to be clarified. The aim of our study was to probe the specific regulatory mechanism of miR-455-3p in AML.
View Article and Find Full Text PDFPotential miRNA-gene interactions determining progression of various ATLL cancer subtypes after infection by HTLV-1 oncovirus.
BMC Med Genomics
March 2023
Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
Article Synopsis
- - ATLL is a fast-growing type of lymphoma caused by HTLV-1 infection, with four main subtypes: acute, lymphoma, chronic, and smoldering, which share common symptoms but lack reliable diagnostic biomarkers.
- - Researchers used weighted-gene co-expression network analysis to identify potentially useful gene and miRNA biomarkers specific to each ATLL subtype through validated miRNA-target gene interactions.
- - The study found key miRNA-gene interactions linked to the disease's progression and suggests these interactions could serve as diagnostic biomarkers for the various ATLL subtypes.
Circ_0060967 facilitates proliferation, migration, and invasion of non-small-cell lung cancer cells by sponging miR-660-3p/UBN2.
Mol Cell Biochem
May 2023
Department of Cardiothoracic Surgery, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, No. 29 Xinglong Lane, Changzhou, 213003, China.
Growing evidence has implied that circular RNAs (circRNAs) are involved in multiple tumors progression. This study firstly uncovered the function of circ_0060967 in non-small-cell lung cancer (NSCLC) progression. Quantitative real-time polymerase chain reaction was employed to monitor circ_0060967, miR-660-3p, and ubinuclein-2 (UBN2) mRNA expression in clinical tissues and cell lines.
View Article and Find Full Text PDFHistone chaperone HIRA complex regulates retrotransposons in embryonic stem cells.
Stem Cell Res Ther
April 2022
State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, 300350, People's Republic of China.
Background: Histone cell cycle regulator (HIRA) complex is an important histone chaperone that mediates the deposition of the H3.3 histone variant onto chromatin independently from DNA synthesis. However, it is still unknown whether it participates in the expression control of retrotransposons and cell fate determination.
View Article and Find Full Text PDFThe ADAM9/UBN2/AKR1C3 axis promotes resistance to androgen-deprivation in prostate cancer.
Am J Cancer Res
January 2022
The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University Taipei, Taiwan.
Metastatic and castration-resistant disease is a fatal manifestation of prostate cancer (PCa). The mechanism through which resistance to androgen deprivation in PCa is developed remains largely unknown. Our understanding of the tumor microenvironment (TME) and key signaling pathways between tumors and their TME is currently changing in light of the generation of new knowledge with regard to cancer progression.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!